Restoring the brain's cleanup cells to help in Lewy body disease
Repopulation of the Microglia/Macrophage Niche in Experimental Lewy Body Disease
This project looks at whether removing and then regrowing the brain's immune cells can help clear harmful protein clumps that damage people with Lewy body disease.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duquesne University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11194408 on NIH RePORTER |
What this research studies
Researchers use a mouse model that copies early Lewy body changes by introducing α-synuclein clumps into smell-related brain areas, producing problems with smell, mood, and memory. They temporarily remove microglia/macrophages with an oral drug and then allow the brain to repopulate those cells to see if fresh cells better clear toxic protein aggregates. The team measures changes in brain pathology and behavior to link microglial repopulation with improvements in disease signs. Findings are intended to guide whether targeting microglia could become a strategy for treating Lewy body disorders.
Who could benefit from this research
Good fit: People diagnosed with Lewy body dementia or Parkinson-related Lewy body disease, especially in earlier stages with smell loss or mood/cognitive changes, would be the likely candidates for future clinical testing of this approach.
Not a fit: Patients without Lewy body pathology or those with very advanced disease stages are less likely to benefit from this microglia-targeting approach.
Why it matters
Potential benefit: If successful, this work could point to new treatments that restore microglial function to help remove α-synuclein clumps and slow or improve symptoms in Lewy body disorders.
How similar studies have performed: Prior animal studies have shown that clearing and repopulating microglia can change disease markers, but this strategy is still novel and has not been proven in people.
Where this research is happening
Pittsburgh, United States
- Duquesne University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Leak, Rehana K — Duquesne University
- Study coordinator: Leak, Rehana K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.